Use of big data for drug development and for public and personal health and care

Lada Leyens*, Matthias Reumann, Nuria Malats, Angela Brand

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalGenetic Epidemiology
Volume41
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • bioinformatics
  • healthcare
  • health systems
  • personalized medicine
  • data commons
  • public health
  • public health genomics
  • structured data
  • unstructured data
  • drug development
  • safety monitoring
  • health policy
  • comparative effectiveness research
  • knowledge visualization
  • cognitive computing
  • IMPLEMENTATION
  • PATTERNS
  • EBOLA

Cite this